See product citations (9)
QUICK LINKS
FK-506, also referred to as Tacrolimus, is an immunosuppressant of the macrolide class. It serves as a valuable compound in the research of preventing organ transplant rejection and treating autoimmune diseases, inflammatory bowel diseases, and specific types of cancers. This potent immunosuppressant functions by binding to and inhibiting the enzyme calcineurin, which plays a role in T-lymphocyte activation. In scientific research, FK-506 has found diverse applications. Studies have employed it to investigate the impact of immunosuppression on the immune system and to explore its effects on the development and progression of certain cancers. Furthermore, FK-506 has been utilized in cell culture studies and investigations into gene expression. By binding to and inhibiting calcineurin activity, FK-506 effectively suppresses T-lymphocyte activation, leading to the suppression of the immune response. FK-506 is an agent that binds to the immunophilin FKBP12 and inhibits PP2B (calcineurin). FK-506, cyclosporin A (sc-3503), and rapamycin (sc-3504) have been shown to inhibit specific transduction pathways, which results in T lymphocyte activation. The compound can also inhibit cAMP levels in the presence of carbachol (sc-202092). Along with cyclosporin A and rapamycin, FK-506 can bind to immunosuppressant binding proteins with high affinity. FK-506 has been found to show neuroregenerative and neuroprotective actions aside from its immunosuppressant activity. Research indicates that FK-506 can stop T cell proliferation in vitro by blocking the generation of a variety of lymphokines, in particular, interleukin (IL-2).
Alexa Fluor® is a trademark of Molecular Probes Inc., OR., USA
LI-COR® and Odyssey® are registered trademarks of LI-COR Biosciences
Ordering Information
Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
FK-506, 5 mg | sc-24649 | 5 mg | $76.00 | |||
FK-506, 10 mg | sc-24649A | 10 mg | $148.00 |